amobarbital and Cardiovascular Pregnancy Complications studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research Excerpts

Excerpt	Relevance	Reference
"Plasma half-lives of amobarbital were determined in newborn children of 10 mothers who had been treated with barbiturates for hypertension in pregnancy for 6 to 42 days prior to delivery."	7.65	Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. ( Clare, RA; Darling, M; Davies, DS; Dollery, CT; Draffan, GH; Hawkins, DF; Krauer, B; Sertel, H; Trudinger, BJ; Williams, FM, 1976)
"Plasma half-lives of amobarbital were determined in newborn children of 10 mothers who had been treated with barbiturates for hypertension in pregnancy for 6 to 42 days prior to delivery."	3.65	Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. ( Clare, RA; Darling, M; Davies, DS; Dollery, CT; Draffan, GH; Hawkins, DF; Krauer, B; Sertel, H; Trudinger, BJ; Williams, FM, 1976)

Research

Studies (1)

Authors

Other Studies

1 other study available for amobarbital and Cardiovascular Pregnancy Complications

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Draffan, GH	1
Dollery, CT	1
Davies, DS	1
Krauer, B	1
Williams, FM	1
Clare, RA	1
Trudinger, BJ	1
Darling, M	1
Sertel, H	1
Hawkins, DF	1